The FDA’s decision to grant Breakthrough Therapy Designation to UPLIZNA underscores the significant unmet medical need in IgG4-RD, a disease characterized by immune-mediated inflammatory flares that ...

U.S. President Donald Trump unveiled global reciprocal tariffs on Wednesday of 10% on all imported goods, with higher rates for some nations that will be equivalent to half of the rates they levy on ...

Investing.com -- KKR, a global investment firm, has withdrawn from a private equity consortium considering a takeover of Gerresheimer AG (BS: GXId ), a German company known for producing pens used to ...